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Histone H3.5 forms an unstable 
nucleosome and accumulates 
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Abstract 
Background: Human histone H3.5 is a non-allelic H3 variant evolutionally derived from H3.3. The H3.5 mRNA is 
highly expressed in human testis. However, the function of H3.5 has remained poorly understood.
Results: We found that the H3.5 nucleosome is less stable than the H3.3 nucleosome. The crystal structure of the 
H3.5 nucleosome showed that the H3.5-specific Leu103 residue, which corresponds to the H3.3 Phe104 residue, 
reduces the hydrophobic interaction with histone H4. Mutational analyses revealed that the H3.5-specific Leu103 
residue is responsible for the instability of the H3.5 nucleosome, both in vitro and in living cells. The H3.5 protein was 
present in human seminiferous tubules, but little to none was found in mature sperm. A chromatin immunoprecipi-
tation coupled with sequencing analysis revealed that H3.5 accumulated around transcription start sites (TSSs) in 
testicular cells.
Conclusions: We performed comprehensive studies of H3.5, and found the instability of the H3.5 nucleosome and 
the accumulation of H3.5 protein around TSSs in human testis. The unstable H3.5 nucleosome may function in the 
chromatin dynamics around the TSSs, during spermatogenesis.
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Background
In eukaryotes, genomic DNA is organized into chro-
matin, which is tightly packaged but allows replication, 
recombination, repair, and transcription [1]. The nucle-
osome, which accommodates about 150 base pairs of 
DNA, is the fundamental structural unit of chromatin 
[2]. The four core histones, H2A, H2B, H3, and H4, are 
the protein components of the nucleosome. These core 
histones contain a conserved histone-fold domain [3]. 
Specific dimer formation occurs between H2A and H2B 
(H2A-H2B), and between H3 and H4 (H3-H4) [2–4]. 
During nucleosome formation, two H3-H4 dimers are 
first assembled on DNA, where they form a subnucleoso-
mal structure called the tetrasome [1–5]. Two H2A-H2B 
dimers are then incorporated into the tetrasome, to form 
the mature nucleosome [1].
For histones H2A, H2B, and H3, non-allelic isoforms 
have been identified as histone variants [6]. Eight his-
tone H3 variants, H3.1, H3.2, H3.3, H3T (H3.4), H3.5, 
H3.X, H3.Y, and CENP-A (CenH3), exist in humans 
[7–18]. These histone H3 variants have distinct expres-
sion profiles during the cell cycle and in different tis-
sues, suggesting their specific functions. H3.1 and H3.2 
are produced in S-phase cells, and are incorporated 
into chromatin during DNA replication [5, 14, 15, 19]. 
In contrast, H3.3 is expressed throughout the cell cycle, 
and can be used as a replacement for histone H3 dur-
ing transcription and DNA repair [5, 14, 15, 20, 21]. 
In addition, H3.3 may be involved in defining specific 
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chromatin domains, such as heterochromatin, euchro-
matin, telomeres, and centromeres [21–24]. H3.X and 
H3.Y are expressed in normal and malignant tissues, 
including brain, and H3.Y is induced by stress stimuli, 
such as nutrient starvation [17]. CENP-A is an essen-
tial component of the chromosomal centromere [7], and 
forms the fundamental centromeric nucleosome [25]. 
H3T is highly expressed in the testis, suggesting that the 
H3T nucleosome may function during spermatogen-
esis [6, 8, 9]. H3T forms nucleosomes in vitro, and was 
incorporated into chromatin when ectopically expressed 
in human cells [26]. However, the H3T nucleosome was 
extremely unstable in vitro, and H3T tagged with green 
fluorescent protein (GFP) was rapidly exchanged in liv-
ing cells [26].
H3.5 is conserved among great apes and Neander-
thals, but not in non-hominid primates [18]. The H3.5 
mRNA is highly expressed in the human testis [18]. In 
cells, ectopically expressed H3.5 is reportedly incorpo-
rated into chromatin, and predominantly localized in the 
euchromatic region [18]. Ectopic H3.5 expression com-
plemented the growth defect of H3.3 knockdown cells, 
suggesting that it has an overlapping function with H3.3, 
as a replacement histone [18]. However, endogenous 
H3.5 has not been detected at the protein level, and the 
biochemical and cellular functions of the H3.5 nucleo-
some have not been clarified so far.
In the present study, we performed comprehensive 
studies of human histone H3.5, including structural and 
biochemical analyses with reconstituted nucleosomes, 
fluorescence recovery after photobleaching analyses with 
living cells, immunohistochemical analyses with human 
testis sections, and chromatin immunoprecipitation fol-
lowed by sequencing (ChIP-Seq).
Results
The H3.5 nucleosome is unstable
Human histone H3.5 lacks the lysine residue present at 
position 37 in the major H3 variants, H3.1, H3.2, and 
H3.3 (Fig.  1a). An amino acid sequence alignment sug-
gested that H3.5 is more similar to H3.3, than to H3.1 
and H3.2. As compared to H3.3, H3.5 has five amino acid 
differences at positions 29, 33, 78, 88, and 103. The Thr29, 
Cys33, Asn78, Val88, and Leu103 residues of H3.5 cor-
respond to the Ala29, Gly33, Lys79, Ile 89, and Phe104 
residues of H3.3, respectively (Fig. 1a). To reveal the bio-
chemical properties of H3.5, we purified H3.5 and other 
H3 variants, including H3.1, H3.3, and H3T (Fig. 1b), and 
then reconstituted nucleosomes containing each of the 
human H3 variants with H2A, H2B, and H4, by the salt 
dialysis method (Fig. 1c). Like the other H3 variants, H3.5 
formed nucleosomes with the core histone ratio of 1:1:1:1 
(Fig. 1c, d).
We next tested the stability of the H3.5 nucleosome, 
using a salt-titration assay. The reconstituted nucle-
osomes were incubated at 50 °C for 1 h, in the presence 
of 0.4, 0.6, 0.7, or 0.8  M NaCl, and the resulting nucle-
osomes were analyzed by native polyacrylamide gel elec-
trophoresis. In this assay, the H3.1 and H3.3 nucleosomes 
were equally stable, and formed nucleosomes in 0.4–
0.8 M NaCl (Fig. 1e). In contrast, the intact H3.5 nucleo-
some was only detected under the 0.4 M and 0.6 M NaCl 
conditions (Fig. 1f, lanes 9 and 10). At higher NaCl con-
centrations (i.e., 0.7 and 0.8  M), the bands correspond-
ing to the H3.5 nucleosome disappeared, indicating 
that the H3.5 nucleosome was disrupted (Fig.  1f, lanes 
11 and 12). Consistent with the previous study [26], the 
H3T nucleosome was disrupted in 0.6 M NaCl, and was 
the most labile (Fig.  1f, lanes 5–8). We previously puri-
fied the complexes corresponding to the bands remain-
ing after the H3T nucleosome disruption, and confirmed 
that these bands were non-specific H2A-H2B-DNA com-
plexes (Fig. 1f, asterisks) [26]. These results showed that 
the H3.5 nucleosome is more stable than the H3T nucle-
osome, but is clearly unstable as compared to the H3.1 
and H3.3 nucleosomes. The formation of unstable nucle-
osomes may be a common feature of the human testis-
specific H3 variants.
Crystal structure of the H3.5 nucleosome
To understand the structural basis for the instability of 
the H3.5 nucleosome, we determined the crystal struc-
ture at 2.8  Å resolution (Fig.  2a; Table  1). The overall 
structure was similar to that of the H3.3 nucleosome 
[27], as expected. H3.5 contains two residues, Asn78 and 
Leu103, which are not conserved in H3.3. Both residues 
do not directly interact with either the H2A-H2B dimers 
or the DNA, which could possibly affect nucleosome 
stability. Leu103, however, is located at the interface of 
H3.5 and H4, and may possibly exhibit reduced hydro-
phobic interactions compared with that of H3.3 (Fig. 2b, 
c). In H3.3, the corresponding residue is Phe104, which 
fills the pocket created by the α1 and α2 helices of H4, 
and apparently forms hydrophobic interactions with the 
side chains of the H4 Ile34, Ile50, and Thr54 residues 
[27]. In contrast, such close hydrophobic interactions 
are not observed around the Leu103 residue in the H3.5 
nucleosome, because Leu has a smaller side chain than 
Phe (Fig.  2b). These data suggested that this structural 
difference may account for the instability of the H3.5 
nucleosome.
The Leu103 residue is responsible for the instability of the 
H3.5 nucleosome
To test whether the H3.5 Leu103 residue contributes to 
the instability of the H3.5 nucleosome, we performed a 
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Fig. 1 The nucleosome containing histone H3.5 is unstable. a Sequence comparison between human H3.1, H3.2, H3.3, H3T, and H3.5. The amino 
acids in H3.5 that differ from those in H3.3 are indicated by black boxes with white characters. The epitope peptide sequence used to generate the 
H3.5 antibody is underlined. The α-helices and β-strands found in the crystal structures of the human nucleosomes are represented on the top of 
the panel. b 18 % SDS-PAGE analysis of purified histones H3.1, H3.3, H3T, and H3.5, stained with Coomassie Brilliant Blue (CBB). c Non-denaturing 
6 % PAGE analysis of purified nucleosomes containing H3.1, H3.3, H3T, and H3.5, stained with ethidium bromide. Lane 1 represents the naked DNA 
used in the nucleosome reconstitution. Nucleosome core particles are denoted by NCPs. d Histone compositions of the purified nucleosomes 
containing H3.1, H3.3, H3T, and H3.5, analyzed by 18 % SDS-PAGE with Coomassie Brilliant Blue staining. e Salt resistance assays of the H3.1 and H3.3 
nucleosomes and f the H3.3, H3T, and H3.5 nucleosomes. Bands corresponding to nucleosomes are indicated by NCPs. Asterisks represent bands 
corresponding to non-nucleosomal DNA-histone complexes [26]
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mutation analysis. There are five amino acid differences 
between H3.3 (Ala29, Gly33, Lys79, Ile89, and Phe104) 
and H3.5 (Thr29, Cys33, Asn78, Val88, and Leu103) 
(Fig.  1a). Since the residue corresponding to Lys37 (or 
Lys36) of H3.3 is missing in H3.5, the H3.5 Asn78, Val88, 
and Leu103 residues correspond to the H3.3 Lys79, Ile89, 
and Phe104 residues, respectively (Fig.  1a). We did not 
target the Thr29, Cys33, and Val88 residues of H3.5 for 
mutagenesis, because they were unlikely to contribute to 
the instability of the H3.5 nucleosome, as the H3.5 Thr29 
and Cys33 residues are located in the flexible N-terminal 
tail region, and the H3.5 Val88 residue is conserved in 
H3.1 (Fig. 1a).
We therefore prepared two H3.5 mutants, N78K and 
L103F, in which the H3.5 Asn78 and Leu103 residues 
were replaced with the corresponding H3.3 residues, 
Lys and Phe, respectively. We also prepared two H3.3 
mutants, K79N and F104L, in which the H3.3 Lys and 
Phe were reciprocally substituted with the correspond-
ing H3.5 residues. These amino acid substitutions in H3.3 
and H3.5 did not affect nucleosome formation by salt 
dialysis (Fig. 3a, b).
We next performed a salt-titration assay with the 
nucleosomes containing the mutant H3.5 and H3.3 under 
the same conditions as in Fig. 1f, in the presence of 0.4, 
0.6, 0.7, or 0.8 M NaCl. The H3.5 N78K nucleosome and 
the wild-type H3.5 nucleosome were similarly unstable 
(Fig. 3c, lanes 1–8). In contrast, the H3.5 L103F nucleo-
some remained intact at higher NaCl concentrations 
































Fig. 2 Crystal structure of the H3.5 nucleosome. a Overall structure of the H3.5 nucleosome. The H3.5, H4, H2A, H2B, and DNA molecules are 
colored sky blue, light orange, pale green, pale yellow, and gray, respectively. The H3.5-specific Leu103 residues are colored red, and their side chains 
are represented. b Stereo view of the H3.5 (sky blue) and H4 (light orange) region around the H3.5 Leu103 residue (red). The 2mFo-DFc electron 
density map around the H3.5 Leu103 residue is shown as a blue mesh, contoured at 1.5σ. The van der Waals surfaces of the H3.5 Leu103 side chain 
atoms, and the H4 Ile34, Ile50, and Thr54 side chain atoms, are represented. c Stereo view of the H3.3 (deep purple) and H4 (light orange) region 
around the H3.3 Phe104 residue in the H3.3 nucleosome structure [PDB:3AV2] [27]. The 2mFo-DFc electron density map around the H3.3 Phe104 
residue is shown as a blue mesh, contoured at 1.5σ. The van der Waals surfaces of the H3.3 Phe104 side chain atoms, and the H4 Ile34, Ile50, and 
Thr54 side chain atoms, are represented
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nucleosome became less stable (Fig.  3d, lanes 9–12), as 
compared to the wild-type H3.3 and H3.3 K79N nucle-
osomes (Fig.  3d, lanes 1–8). To confirm that the H3.5-
specific Leu103 residue directly weakens the DNA 
binding of the H3-H4 complex, we reconstituted tetras-
omes, in which the H3.5-H4, H3.3-H4, H3.5 L103F-H4, 
or H3.3 F104L-H4 tetramer complex wraps the DNA 
(Fig.  4a, b). We then performed the thermal stability 
assay [28]. In this assay, the thermal dissociation of his-
tones from the DNA can be monitored as a fluorescence 
signal (Fig. 4c). As shown in Fig. 4d, the H3.5 tetrasome 
was disrupted at lower temperatures than the H3.3 tet-
rasome, indicating that H3.5 associates with DNA more 
weakly than H3.3. This is consistent with the H3.5 insta-
bility observed in the salt-titration assay (Figs.  1, 3). 
Interestingly, the H3.5 tetrasome instability was partially 
compensated by the H3.5 L103F mutation (Fig. 4d). Con-
sistently, the H3.3 F104L mutation reduced the tetrasome 
stability (Fig.  4d). These data support the above notion 
that the H3.5-specific Leu103 residue, which structur-
ally reduces the hydrophobic interaction with H4, is at 
least partially responsible for the instability of the H3.5 
nucleosome.
Higher mobility of GFP‑tagged H3.5 in living cells
To examine whether H3.5 is incorporated into nucle-
osomes less stably than H3.3 in living cells, we performed 
fluorescence recovery after photobleaching (FRAP), 
using HeLa cells expressing GFP-H3.5 and GFP-H3.3 
[26, 29, 30]. One-half of the nucleus was bleached, and 
the fluorescence intensity was measured in the presence 
of cycloheximide, to suppress the fluorescence recovery 
due to new protein synthesis. As shown in Fig. 5a, both 
GFP-H3.5 and GFP-H3.3 exhibited slow recovery, con-
sistent with their incorporation into chromatin as H3.1-
GFP [31]. Quantitative measurements then indicated that 
GFP-H3.5 recovered substantially faster than GFP-H3.3 
(Fig.  5b), suggesting that nucleosomal H3.5 exchanges 
more rapidly than H3.3.
FRAP analyses of the mutants further revealed that 
the GFP-H3.5 L103F mutant recovered more slowly 
than the reciprocal GFP-H3.3 F104L mutant (Fig. 5c, d). 
These results indicated that the H3.5-specific Leu103 
residue is critical for the rapid exchange of H3.5 in liv-
ing cells, in good agreement with the in vitro salt-titra-
tion data.
Presence of human histone H3.5 in testicular cells 
within seminiferous tubules
Since the endogenous H3.5 protein has not been 
detected, due to the lack of a specific antibody, we gen-
erated a specific monoclonal antibody directed against 
H3.5, using a peptide containing H3.5 Thr22-Arg41 
(MAB Institute, Inc.). A Western blotting analysis 
showed that the H3.5 antibody specifically reacted to 
H3.5, but not to other variants (i.e., H3.1, H3.2, H3.3, 
and H3T) (Fig. 6a). In addition, we performed a Western 
blotting analysis with human testicular cell extracts from 
three individuals, and confirmed that the H3.5 antibody 
specifically detected endogenous H3.5 with low back-
ground signals (Fig. 6b). By using this antibody in immu-
nohistochemical analyses, we detected positive signals in 
human testis sections, indicating that H3.5 is expressed 
at the protein level in cells within seminiferous tubules 
(Fig.  7a). Major histone H3 variants, such as H3.1 and 
H3.3, were also detected in testis sections (Fig.  7b, c). 
Interestingly, H3.5 was clearly present in spermatogonia 
and/or primary spermatocytes, in which the first mei-
otic cell division is not completed (Fig. 7a). However, the 
endogenous H3.5 protein was not detected in mature 
sperm by Western blotting using the H3.5-specific anti-
body, although H3 was clearly detected when the C-ter-
minus-specific antibody was used (Fig.  7d), suggesting 
that H3 variants other than H3.5 are present in mature 
sperm. These results prompted us to test the genomic 
localization of endogenous H3.5 in human testicular 
cells.
Table 1 Summary of data collection and refinement statis-
tics




 Space group P212121
 Cell dimensions
 a, b, c (Å) 104.89, 109.13, 174.49
 α, β, γ (°) 90.00, 90.00, 90.00
 Resolution (Å) 50.00–2.80 (2.90–2.80)
 Rsym 9.4 (50.0)
 I/σI 10.2 (2.7)
 Completeness (%) 99.5 (96.5)
 Redundancy 8.8 (6.4)
Refinement
 Resolution (Å) 37.81–2.80









 Bond lengths (Å) 0.005
 Bond angles (°) 0.815
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Transcription independent accumulation of H3.5 
around transcription start sites in human testis
To address the genomic incorporation pattern of endog-
enous H3.5, we performed chromatin immunoprecipi-
tation coupled with deep sequencing (ChIP-Seq). We 
analyzed the distribution of H3.5 and H3.3 on the human 
genome. About 75  % of the H3.5 peaks were localized 
around genes (including 5′UTR, promoter-TSS, exon, 
intron, TES, and 3′UTR), as were the H3.3 peaks, although 
H3.5 was preferentially localized around exons, as com-
pared to H3.3 (Fig.  8a). Additionally, H3.5 was enriched 
around transcription start sites (TSSs), especially down-
stream of TSSs, independently of its expression level 
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Fig. 3 Mutational analysis of H3.5 and H3.3. a Non-denaturing 6 % PAGE analysis of the purified nucleosomes containing H3.5 and H3.3 mutants, 
stained with ethidium bromide. Lane 1 represents the naked DNA used in the nucleosome reconstitution. Nucleosome core particles are denoted 
by NCPs. b Histone compositions of the purified nucleosomes containing H3.3 and H3.5 mutants, analyzed by 18 % SDS-PAGE with Coomassie 
Brilliant Blue staining. c Salt resistance assays of the H3.5 mutant nucleosomes, and d the H3.3 mutant nucleosomes. Bands corresponding to nucle-
osomes are indicated as NCPs. Asterisks represent bands corresponding to non-nucleosomal DNA-histone complexes [26]
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its gene expression levels (Fig. 8c), as demonstrated previ-
ously [32]. Around TSSs, H3.5 was incorporated into both 
active and silent genes, while H3.3 was predominantly 
incorporated into active genes (Fig. 8d).
Discussion
Histone H3.5 in human seminiferous tubules
During spermatogenesis, the haploid genome becomes 









































































































































Fig. 4 Thermal stability of tetrasomes. a Purified tetrasomes containing H3.3 (lane 2), H3.3 F104L (lane 3), H3.5 (lane 4), and H3.5 L103F (lane 5) 
were analyzed by non-denaturing 6 % PAGE analysis. The gel was stained with ethidium bromide. Lane 1 represents the naked DNA used for the 
reconstitution of tetraosomes. b Histone compositions of the purified tetrasomes. Purified tetrasomes containing H3.3 (lane 2), H3.3 F104L (lane 
3), H3.5 (lane 4), and H3.5 L103F (lane 5) were analyzed by 18 % SDS-PAGE with Coomassie Brilliant Blue staining. c The schematic representation of 
thermal stability assay. d The thermal stability curves for the tetrasomes containing H3.3 (open triangles), H3.3 F104L (closed triangles), H3.5 (open 
circles), and H3.5 L103F (closed circles) are presented. Three experiments were independently performed and averages of these results were plotted 
with standard deviation values
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requires robust chromatin reorganization, and eventu-
ally the histones are largely replaced by protamines [33–
35]. Some human histone variants, including TSH2B and 
H3T, are highly expressed in testis, at least at the mRNA 
level, and may perform specific functions in the chro-
matin reorganization during spermatogenesis. H3.5 is a 
relatively newly identified variant, and its mRNA is also 
highly expressed in testis, as compared to other tissues 
[18]. However, the endogenous H3.5 protein has not 
been detected, due to the lack of its specific antibody. 
To overcome this problem, we successfully produced 
an H3.5-specific monoclonal antibody, which did not 
cross-react with other human H3 variants, H3.1, H3.2, 
H3.3, and H3T (Fig. 6). This H3.5 monoclonal antibody 
allowed us to study the endogenous H3.5 in human 
testis.
Our immunohistochemical analysis with human testis 
sections detected H3.5 at the protein level in seminifer-
ous tubules, especially in the cells before or during the 
first meiotic cell division (Fig. 7). However, H3.5 may not 
be retained in mature sperm (Fig. 7). Therefore, H3.5 may 
play a role in preparing the proper chromatin landscape 
for events before or during the first meiotic cell divi-
sion. Stage-specific production has been reported for the 
mouse testis-specific H2B variant, TH2B [36], which is 
an ortholog of human TSH2B [37]. However, the timing 
of TH2B expression is clearly different from that of H3.5. 
TH2B is barely detected in spermatogonia, but exists in 
spermatids. In contrast, H3.5 can be detected in sper-
matogonia, but not in mature sperm, although we can-
not exclude the possibility that a trace amount of H3.5 
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Fig. 5 Mobility of GFP-H3.5 and GFP-H3.3 in living cells. a FRAP analysis of HeLa cells expressing GFP-H3.3 or GFP-H3.5. Bar indicates 10 μm. b The 
mobility of GFP-H3.3 or GFP-H3.5 in living cells, analyzed by bleaching one-half of the nucleus. The averages of the relative fluorescence intensity 
of the bleached area were plotted with the standard deviations (n = 10–11). c FRAP analysis of HeLa cells expressing GFP-H3.3 F104L or GFP-H3.5 
L103F. Bar indicates 10 μm. d The mobility of the GFP-H3.3 F104L or GFP-H3.5 L103F mutant in living cells, analyzed by bleaching one-half of the 
nucleus. The averages of the relative fluorescence intensity of the bleached area were plotted with the standard deviations (n = 10–11)
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stage-specific incorporation of different histone variants 
may play a role in the maturation of sperm chromatin.
The nucleosome containing histone H3.5 is unstable
We found that the H3.5 nucleosome is quite unstable, as 
compared to the H3.3 nucleosome in vitro (Fig. 1). Con-
sistently, the mobility of H3.5 is remarkably faster than 
that of H3.3 in living cells (Fig. 5). In humans, the expres-
sion level of another histone H3 variant, H3T, is also high 
in the testis, but low in somatic cells [6, 8, 9]. The nucleo-
some containing H3T is quite unstable in vitro and in liv-
ing cells [26]. Nucleosome instability was also reported 
with a mouse testis-specific H2A variant, H2AL2 [38]. 
Therefore, instability may be a common characteristic 
of the testis-specific nucleosomes. The unstable nature 
of the H3.5 nucleosome may be suitable for further 
replacement with transition proteins and protamines. 
H3.5 incorporation may also regulate the transcription of 
the genes required during the early stages of spermato-
genesis. However, H3.3 appears to be more relevant for 
regulating transcription during spermatogenesis, as its 
incorporation is correlated with the gene expression 
level. In contrast, H3.5 incorporation may function to 
transiently mark TSSs to assist in the replacement with 
H3.3, depending on gene expression. Histone acetylation 
may also play an important role in global and/or local 
histone exchange in the human testis, as shown in the 
mouse [39].
Our present and previous [26] studies demonstrated 
that the H3.5 Leu103 and H3T Val111 residues are pre-
dominantly responsible for the instability of the H3.5 and 
H3T nucleosomes, respectively. These H3.5 Leu103 and 
H3T Val111 residues correspond to Phe and Ala in H3.3 
(and canonical H3.1), respectively. In the crystal structure 
of the H3.5 nucleosome, the H3.5 Leu103 residue forms 
fewer hydrophobic interactions with H4, as compared 
to the corresponding H3.3 Phe104 residue, and does not 
induce substantial structural distortion around the resi-
due (Fig. 2). In contrast, the H3T Val111 residue induces 
local structural distortion around position 111 [26]. 
Therefore, the H3.5 Leu103 and H3T Val111 residues 
induce nucleosome instability by different mechanisms.
The H3.5 Leu103 and H3T Val111 residues are both 
located in the vicinity of the nucleosomal dyad. Intrigu-
ingly, genetic and biochemical studies have identified a 
mutation at Arg116 (to His) that destabilizes the nucle-
osome [40, 41]. This H3 mutation is known as a Sin 
mutation that alleviates the requirement for the Swi/
Snf nucleosome-remodeling factor [40, 42]. The Sin 
phenotype has also been found in Saccharomyces cere-
visiae with the H3 Ala111 to Gly mutation [43]. In addi-





























































Fig. 6 The H3.5-specific antibody. a Western blot analysis of H3.5. Purified H3.1, H3.2, H3.3, H3T, and H3.5 were separated by 18 % SDS-PAGE, and 
analyzed by Western blotting with the anti-H3.5 monoclonal antibody (left panel). The 18 % SDS-PAGE gel stained with Coomassie Brilliant Blue is 
presented in the right panel. b Western blot analyses of endogenous H3.5 (left panel) and all H3 s (right panel). Endogenous H3.5 and H3 proteins 
were detected by Western blotting with the anti-H3.5 monoclonal antibody (left panel) and the H3 C-terminus-specific antibody (right panel), 
respectively
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cerevisiae suggested that the mutation of the 103rd or 
104th residue of H3 may affect transcriptional regula-
tion, probably through chromatin remodeling [44]. The 
crystal structure of the nucleosome containing the Sin 
mutations revealed that the H3 Arg116 mutation may 
allosterically destabilize the nucleosome, by reducing the 
number of histone-DNA and/or histone–histone interac-
tions [45]. Therefore, the H3 C-terminal region, which 
is located near the nucleosomal dyad, is important for 
stable nucleosome formation, and amino acid substitu-
tions within this region sensitively affect the nucleosome 
stability.
In addition to the testis, small amounts of H3.5 mRNA 
expression are also observed in ejaculate, leukocytes, and 
liver [18]. Proteins specifically produced in the testis have 
frequently been found as inappropriately overexpressed 
proteins in cancer cells. Furthermore, several missense 
mutations of the human H3F3C gene, encoding H3.5, 
have recently been found in tumors [46], including 
Val100 and Arg130. Like the L103F and Sin mutations, 
the mutations of these residues may also influence the 
nucleosome stability, by affecting the intra-nucleosomal 
interactions of amino acid residues near the nucleosomal 
dyad [40–45]. Together, these findings suggest that the 
inappropriate production of the H3.5 mutant may com-
promise proper chromosomal function in tumor cells. It 
is thus intriguing to study the correlation between H3.5 
nucleosome stability and cancer predisposition.
Conclusions
We found that the H3.5 nucleosome is less stable than the 




































Fig. 7 H3.5 exists in human testicular cells within seminiferous tubules. a–c Human testis sections immunohistochemically stained with the 
anti-H3.5 (a), anti-H3.1 (b), and anti-H3.3 (c) monoclonal antibodies. Bars indicate 50 μm. Arrows and arrow heads in the enlarged picture in panel 
(a) primary spermatocytes at leptotene and preleptotene stages, respectively. d Western blotting. Proteins from isolated sperm were separated by 
15 % SDS-PAGE, transferred to a PVDF membrane, and probed with the anti-H3.5 monoclonal antibody (left panel) or the anti-H3 C-terminal peptide 
polyclonal antibody (right panel). Recombinant H3.5-H4 and H3.3-H4 complexes were used for controls. Asterisks represent the degraded H3
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is responsible for the instability of the H3.5 nucleosome, 
both in vitro and in living cells. We discovered that the 
H3.5 protein is actually present in seminiferous tubules 
in humans. Although the sample was limited to a single 
donor, our ChIP-seq analysis suggests that the endog-
enous H3.5 specifically accumulates at transcription start 
sites in human testicular cells. These findings provide 
new important insights into the role of H3.5 during sper-
matogenesis. Future analyses using more specimens from 
various donors, including those suffered from diseases, 
will be required for fully understanding the function of 
H3.5 in the chromatin reorganization.
Methods
Expression and purification of recombinant human 
histones
Human histones H2A, H2B, H3.1, H3.2, H3.3, H3T, H3.5, 
and H4 were produced in Escherichia coli cells [47], and 
were purified by the previously described method [26]. 
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a
Fig. 8 Endogenous H3.5 specifically accumulates around transcription start sites in human testicular cells. a Graphic representation of the distribu-
tion of endogenous H3.5 and H3.3 on the human genome. 5′-UTR: 5′-untranslated region. 3′-UTR: 3′-untranslated region. TSS: transcription start 
site. TES: transcription end site. b Aggregation plots of the endogenous H3.5 localization around TSSs. c Aggregation plots of the endogenous H3.3 
localization around TSSs. Signals for genes with various expression levels are plotted against relative distance from TSS. d Gene expression-inde-
pendent incorporation of endogenous H3.5 in human testis. The increment of each H3.3 and H3.5 ChIP-Seq signal intensity is shown with respect 
to the gene expression levels (per 10 %ile FPKM). The red and blue lines indicate the average increments of H3.3 and H3.5, respectively. The standard 
error (S.E.) of the signal intensities is indicated as a dotted line
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system was constructed by site-directed mutagenesis, 
with the H3.3 expression vector as the template. The 
H3.3 and H3.5 mutants were also constructed by site-
directed mutagenesis, and were prepared by the previ-
ously described method [26].
Preparation of histone complexes
Freeze-dried H2A (2  mg), H2B (2  mg), H4 (1.6  mg), and 
either H3.5 (2.2 mg), H3.3 (2.2 mg), or H3.1 (2.2 mg) were 
mixed in unfolding buffer (20 mM Tris–HCl (pH 7.5), 7 M 
guanidine hydrochloride, and 20 mM 2-mercaptoethanol), 
and dialyzed against refolding buffer (10 mM Tris–HCl (pH 
7.5), 2 M NaCl, 1 mM EDTA, and 5 mM 2-mercaptoetha-
nol). The resulting histone octamers were purified by Super-
dex 200 gel filtration chromatography (GE Healthcare).
The H3.5-H4, H3T-H4, H3.3-H4, and H2A-H2B com-
plexes were reconstituted as follows. Purified H3.5, H3T, 
or H3.3 was combined with H4 at a 1:1 molar ratio in 
unfolding buffer, and the mixture was dialyzed against 
refolding buffer, followed by stepwise salt-dialysis with 
refolding buffer containing 1, 0.5, and 0.1 M NaCl. Puri-
fied H2A and H2B were mixed at a 1:1 molar ratio in 
unfolding buffer, and the mixture was dialyzed against 
refolding buffer. The resulting H3.5-H4, H3T-H4, H3.3-
H4, and H2A-H2B complexes were purified by Superdex 
200 gel filtration chromatography.
Preparation of nucleosomes
The nucleosomes were reconstituted using the 146 base-
pair human α-satellite DNA [2], prepared by the method 
described previously [48]. For the H3.5, H3.3, and H3.1 
nucleosomes, the purified histone octamers were mixed 
with the 146 base-pair DNA in a solution containing 2 M 
KCl. For the H3T nucleosome, the H3T-H4 and H2A-
H2B complexes were mixed with the 146 base-pair DNA 
in a solution containing 2 M KCl [26]. The nucleosomes 
were reconstituted by the salt-dialysis method, heated at 
55 °C for 2 h, and further purified from the free DNA and 
histones by non-denaturing polyacrylamide gel electro-
phoresis (Prep Cell, Bio-Rad).
Salt resistance assay for nucleosome stability
The nucleosomes (240 ng/μl) were incubated in the pres-
ence of 0.4, 0.6, 0.7, and 0.8 M NaCl in 36 mM Tris–HCl 
(pH 7.5) buffer, containing 1.8  mM EDTA and 1.8  mM 
dithiothreitol, at 50 °C for 1 h. After this incubation, the 
NaCl concentrations of the samples were adjusted to 
0.4 M, and the samples were analyzed by non-denaturing 
6 % PAGE with ethidium bromide staining.
Crystallization and structure determination
The crystallization and structural determination of the 
H3.5 nucleosome were performed by methods similar 
to those reported previously [25–27]. Crystals of the 
purified H3.5 nucleosomes were obtained by the hang-
ing drop vapor diffusion method. The drop included the 
H3.5 nucleosome (1 μl) and a solution (1 μl) containing 
20 mM potassium cacodylate (pH 6.0), 50 mM KCl, and 
75–155  mM MnCl2. The reservoir solution contained 
20 mM potassium cacodylate (pH 6.0), 35–40 mM KCl, 
and 50–80  mM MnCl2. Crystals typically appeared 
within 7–10 days, and grew to their full size over a period 
of 2–3 weeks. The H3.5 nucleosome crystals were soaked 
for 5–10 s at room temperature in a cryo-protectant solu-
tion, containing 20  mM potassium cacodylate (pH 6.0), 
40 mM KCl, 70 mM MnCl2, 29 % 2-methyl-2,4-pentane-
diol, and 2 % trehalose, and were flash-cooled in a stream 
of N2 gas (100  K). The H3.5 nucleosome crystals con-
tained one nucleosome per asymmetric unit. Diffraction 
data were obtained at a wavelength of 1.000 Å, using the 
synchrotron radiation source at the beamline BL41XU 
station of SPring-8, Harima, Japan.
Diffraction data were integrated and scaled with the 
HKL2000 program [49]. The data were processed using 
the CCP4 program suite [50]. The structure of the H3.5 
nucleosome was solved by the molecular replacement 
method, using PHASER [51] and the H3.3 nucleosome 
structure [PDB:3AV2] as the search model [27]. The 
structure of the H3.5 nucleosome was refined using PHE-
NIX [52], and the model was built using COOT [53]. 
Following the rigid body refinement, iterative rounds of 
xyz-coordinate, real-space, individual B-factor, and occu-
pancy refinements were performed, with optimizing the 
X-ray/stereochemistry and the X-ray/B-factor weights. 
Secondary structure restraints and non-crystallographic 
symmetry restraints were applied for the refinements. 
The Ramachandran plot of the final H3.5 nucleosome 
structure showed 99.2  % of the residues in the favored 
region, 0.8 % of the residues in the allowed region, and no 
residues in the outlier region, as validated with the Mol-
Probity program [54]. A summary of the data collection 
and refinement statistics is provided in Table 1. All struc-
ture figures were created using the PyMOL program [55].
Thermal stability assay
The tetrasomes were reconstituted by the salt dialysis 
method, and were purified by non-denaturing poly-
acrylamide gel electrophoresis (Prep Cell, Bio-Rad), as 
previously described [28]. The reconstituted tetrasomes, 
containing the H3.5-H4 or H3.3-H4 tetramer and the 146 
base-pair DNA, were subjected to the thermal stability 
assay, in 19 µl of 20 mM Tris–HCl (pH 7.5), 1 mM DTT, 
and 1 mM EDTA. The fluorescence signals were detected 
by a StepOnePlus™ Real-Time PCR unit (Applied 
Biosystems) with a temperature gradient from 26 to 
95 °C, in steps of 1 °C/min. The fluorescence intensity was 
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normalized, as follows: F(T)normalized  =  [F(T)  −  F(26)]/
[F(95)  −  F(26)], and plotted against the temperature. 
F(T) indicates the fluorescence intensity at a particular 
temperature.
FRAP analysis
DNA fragments encoding H3.5, H3.3, and their mutants 
were cloned into the pEGFP-C3 vector (Clontech). HeLa 
cells were transfected with the expression vectors using 
Lipofectamine 2000 (Life Technologies), and cultured 
in 1 mg/ml G418 (Nacalai Tesque) to select those stably 
expressing GFP-tagged H3 proteins. Cells were grown 
in Dulbecco’s modified Eagle’s medium, supplemented 
with 10 U/ml penicillin, 50  μg/ml streptomycin, and 
10 % fetal calf serum, on a glass-bottom dish (Mat-tek). 
FRAP was performed using a confocal microscope (FV-
1000; Olympus), featuring a heated stage supplemented 
with 5 % CO2 [29]. A confocal image of a field contain-
ing about 10 nuclei was collected with a 60×  UPlanSApo 
NA =  1.35 lens (800 ×  800 pixels, zoom 2, scan speed 
2  μs/pixel, pinhole 800  μm, Kalman filtration for four 
scans, LP505 emission filter, and 0.2  % transmission of 
488-nm Ar laser). Afterward, one-half of each nucleus 
was photobleached using 90  % transmission of the 
488 nm laser (two iterations), and images were collected 
using the original setting at 1 min intervals for 120 min. 
Fluorescence intensities of the bleached, unbleached, and 
background areas were measured using Image J 1.46r. 
After background subtraction, the relative intensity of 
the bleached area to the unbleached area was determined 
and normalized to the initial value before bleaching.
The H3.5 monoclonal antibody
The H3.5-specific mouse monoclonal antibody was 
produced (MAB Institute Inc.) using an H3.5-specific 
synthetic peptide (TKAARKSTPSTCGVKPHRYRC) 
coupled to keyhole limpet hemocyanin. After hybri-
doma generation, clones were screened by ELISA, using 
plates coated with the H3.5-specific or H3.3-specific 
(TKAARKSAPSTGGVKKPHRYRC) peptide conjugated 
with bovine serum albumin. ELISA-positive clones were 
further screened by immunofluorescence using HeLa 
cells expressing GFP-H3.5 and GFP-H3.3, and by West-
ern blotting using recombinant histone H3 variants (i.e., 
H3.1, H3.2, H3.3, H3T, and H3.5).
Immunohistochemistry
Human testicular samples were obtained, fixed in Bouin’s 
solution for 2 h and embedded in paraffin. After depar-
affinization, 5-μm sections were incubated with hydro-
gen peroxide to inhibit endogenous peroxidases. After 
non-specific binding was blocked by rabbit serum, the 
slides were incubated with the culture supernatant of the 
hybridoma producing the anti-H3.5 monoclonal anti-
body (1:100 dilution) for 24 h at room temperature, and 
endogenous H3.5 was visualized using the avidin–biotin 
complex method. The sections were then counterstained 
with haematoxylin. In the negative control slides, the pri-
mary antibody was omitted. Endogenous H3.1 and H3.3 
were detected by the same method as that for the H3.5 
detection, using the H3.1-specific monoclonal antibody 
[56] or the H3.3-specific monoclonal antibody [57].
Detection of histone H3 in mature sperm cells
Ejaculated sperm cells were obtained with informed 
consent from 12 anonymized Japanese males. Mixed 
sperm cells were washed 3 times with PBS, and were sus-
pended in lysis buffer (20 mM Tris–HCl (pH 8.0), 10 % 
glycerol, 0.2 mM EDTA, 0.1 % Tween 20, 150 mM KCl, 
0.2 mM PMSF, and 0.8 mM 2-mercaptoethanol). The col-
lected samples were sonicated six times for 30 s in lysis 
buffer. The proteins in the cell lysate were fractionated 
by 15  % SDS-PAGE, transferred to a PVDF membrane, 
and detected with an anti-H3 rabbit polyclonal antibody 
(#9715, Cell Signaling Technology, Inc.) or the culture 
supernatant of the hybridoma producing the anti-H3.5 
monoclonal antibody (1:100 dilution).
Chromatin immunoprecipitation
Human testis homogenates were fixed with 1 % formal-
dehyde in PBS(+) buffer. The fixed human testis homoge-
nates were precipitated then suspended in RIPA buffer 
(50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 2 mM EDTA, 
1 % NP-40, 0.5 % sodium deoxycholate, 0.1 % SDS, and 
protease inhibitor cocktail; Nacalai Tesque Inc.), instead 
of ChIP buffer. The sample was sonicated twenty times 
for 5  s. The sheared samples were then centrifuged at 
15,000×g for 10  min. The supernatant, containing the 
DNA, was incubated with magnetic beads conjugated 
with the anti-H3.3 rat monoclonal antibody [57] or the 
culture supernatant of the hybridoma producing the 
anti-H3.5 mouse monoclonal antibody, at 4 °C overnight 
with rotation. The immune complexes were pulled down, 
washed with RIPA buffer and TE buffer (both twice), and 
then eluted from the beads using 1  % SDS and 0.02  % 
Proteinase K (Nacalai Tesque Inc.) in TE. The cross-links 
were reversed by an incubation for 4 h at 65 °C, followed 
by an incubation for 1  h at 50  °C. The DNA samples 
were then purified with a Qiaquick PCR purification kit 
(Qiagen, Valencia, CA, USA). The ChIP library was pre-
pared with the Illumina protocol, and the samples were 
sequenced on an Illumina HiSeq-1500 system.
ChIP‑Seq data analysis
Sequenced reads of H3.3 and H3.5 ChIP-Seq were 
mapped onto the human genome (hg19) with Bowtie 
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(version 0.12.8), with the parameters “–v 2 –m 1”. The 
uniquely mapped and PCR duplicates-removed reads, 
obtained using SAMTools [58], were utilized for further 
analysis. The number of reads for input, H3.5, and H3.3 
were 26,524,770, 14,818,772, and 24,356,280, respectively. 
The estimation of normalized ChIP-Seq signal intensities 
was calculated as follows. First, we counted the mapped 
reads throughout 1000 bp intervals (bins) on the genome, 
and then the counts were normalized as RPKM (Reads 
Per Kilobases per Million reads) [59]. Finally, the ChIP-
Seq signal intensities were calculated as the RPKM dif-
ferences between the ChIP and input DNA-control data 
(i.e., ChIP–control) on each bin. For the peak distribu-
tion analysis (percentages of peak localizations on each 
genomic category), the HOMER software [60] was uti-
lized. Peaks were called using the MACS2 software (ver-
sion 2.1.0) [61] with the following parameters: q value 
<0.1 for H3.5, p value <0.01 for H3.5.
mRNA‑Seq and analysis
Total RNA was extracted from human testis homogen-
ates. cDNA synthesis was performed with Primescript 
Reverse Transcriptase and a dT primer (Takara Bio 
Inc.). The preparation of the mRNA-Seq library and the 
sequencing were performed according to the Illumina 
protocol. Sequenced reads were mapped onto the human 
genome (hg19) with Tophat (version 2.0.8). The gene 
expression levels (FPKM; Fragments Per Kilobase of exon 
per Million mapped sequence reads) were estimated with 
Cufflinks (version 2.0.1), using the mapped reads. The 
default parameters of the software were employed. We 
defined ten expression groups, labeled q0–10  %, q10–
20 %,…, q90–100 %, with respect to the FPKMs of genes, 
which define the 10 percentile intervals of all FPKMs; i.e., 
the genes were ordered by the FPKMs and then separated 
into ten groups with equal numbers of members. The 
genes with FPKM = 0 were excluded.
Data access
The atomic coordinates of the H3.5 nucleosome have 
been deposited in the RCSB Protein Data Bank, with the 
RCSB ID code [PDB:4Z5T]. Deep-sequencing data have 
been deposited in the DDBJ sequence read archive, with 
the accession number [DDBJ:DRA002604].
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